According to the latest report by IMARC Group “Artificial Insemination Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global artificial insemination market reached a value of US$ 1.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2027, exhibiting a CAGR of 8.6% during 2022-2027.

Artificial insemination refers to an assisted fertilization treatment wherein the sperm is artificially introduced into the cervix and uterus of a female. This procedure is employed through artificial insemination homologous (AIH), artificial insemination donor semen (AID), or intrauterine insemination (IUI). Artificial insemination is beneficial for infertility, old age, poor sperm quality, polycystic ovary syndrome (PCOS), and endometriosis. Other than this, artificial insemination is also adopted in animal breeding to conserve endangered species.

Request for a free sample copy of this report: https://www.imarcgroup.com/artificial-insemination-market/requestsample

Market Trends:

The growing rate of infertility, changing lifestyles, and increasing awareness regarding the availability of alternative reproductive treatments are majorly driving the global artificial insemination market. The legalization of same-sex marriage by governments of various nations is further contributing to the market growth. Moreover, there has been an increase in the adoption of artificial insemination in the breeding of livestock animals as it is considered more hygienic, thereby preventing the spread of zoonotic diseases. This is also supported by the escalating demand for animal-based proteins.

Breakup by Type:

• Intrauterine

• Intracervical

• Intravaginal

• Intratubal

Breakup by Source Type:

• AIH-Husband

• AID-Donor

Breakup by End Use:

• Hospitals and Clinics

• Fertility Centers

• Others

Market Breakup by Region:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

Competitive Landscape with Key Player:

• Conceivex Inc.

• FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation)

• Genea Limited

• Genus plc

• Hamilton Thorne Inc.

• Hi-Tech Solutions

• Kitazato Corporation

• Pride Angel

• Rinovum Women’s Health LLC

• Rocket Medical plc

• TenderNeeds Fertility LLC

• Vitrolife AB.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=4023&flag=C

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal